Cytogel Pharma Stock
Cytogel Pharma is a bio-pharmaceutical development company that pursues strategic opportunities for pharmaceutical product development.
Sign up today and learn more about Cytogel Pharma Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Cytogel Pharma Stock
Cytogel Pharma (Cytogel) is a bio-pharmaceutical development company founded in 2002 to pursue strategic opportunities for pharmaceutical product development. The company focuses on acquiring promising early-stage programs that offer significant potential both as platform technologies and high value product candidates. Milestone-defined investment of corporate resources permits the company to enhance product value for partnering or licensing, while retaining optimal equity value for our investors. Cytogel is venture backed by Centripetal Capital Partners.
C. Dean Maglaris
Licensing and Business Development
James J. Hamsher
Chief Scientific Officer/cofounder & Director
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase